Press Release

Hereditary Angioedema Treatment Market was Worth US$ 1883.1 Mn in 2017, Increasing Healthcare Expenditure to Enable Growth, says Fortune Business Insights

Hereditary Angioedema Treatment Market by Top Key Players are BIOCRYST PHARMACEUTICALS INC., Ionis Pharmaceuticals Inc., Attune Pharmaceuticals, Arrowhead Pharmaceuticals Inc., and Adverum.

Hereditary Angioedema Treatment MarketThe global hereditary angioedema treatment market to gain from increasing incidences of genetic mutation. Recently Fortune Business Insights, published a report titled, “Hereditary Angioedema Treatment Market Size, Share and Global Trend by Drug Class (C-1 Esterase Inhibitors, Bradykynin Receptor Antagonist, Kallikrein Inhibitors), Application (Prophylaxis, Treatment), Route of Administration (IV, Subcutaneous), Distribution Channel (Hospital Pharmacy, Retail Pharmacy) and Geography Forecast till 2025.” As per the report, the global hereditary angioedema treatment market was worth US$ 1883.1 Mn in 2017. The global market is anticipated to expand at a CAGR of 16.8% and reach US$ 6533.3 Mn by the end of 2025. The report classifies the global hereditary angioedema treatment market in various segments and offer a comprehensive overview.

Request a Sample Copy of Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/hereditary-angioedema-treatment-market-100164

some of the key players in the global Market:

  • BIOCRYST PHARMACEUTICALS INC.
  • Ionis Pharmaceuticals Inc.
  • Attune Pharmaceuticals
  • Arrowhead Pharmaceuticals Inc.
  • Adverum

According to the report, the hereditary angioedema treatment market in North America was valued at US$ 1752.2 Mn in 2017. The growth witnessed is attributable to high prevalence of hereditary angioedema in the region. North America may remain dominant in the global market through the forecast period (2018-2025) also. Presence of an established healthcare system and increasing healthcare expenditure are a few factors anticipated to contribute the expansion of the hereditary market in North America.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/hereditary-angioedema-treatment-market-100164

C-1 Esterase Inhibitor Segment to Dominate Global Market During Forecast Period

In terms of drug class, the C-1 esterase inhibitor is the most popular drug and dominated the global market in 2017. The segment accounted for 61.3% of the global market in 2017. The trend is unlikely to change during the forecast period 2018-2025 owing to the drug’s reliability among patients and practitioners.

Increasing awareness about the disorder and rising prevalence of the hereditary angioedema are some factors expected to drive the global hereditary angioedema treatment industry during the forecast period. Additionally, technological developments in the hereditary angioedema treatment devices and equipment is expected to boost the global market.

Shire, CSL Behring, and Pharming Group NV to Lead the Global Market

The global market is witnessing entry of new players in the market. However, at present Pharming Group NV, Shire, and CSL Behring are together leading the global market owing to the organization’s strong distribution network. Some of the other companies operating in the global hereditary angioedema treatment market are BIOCRYST PHARMACEUTICALS INC., Ionis Pharmaceuticals Inc., Attune Pharmaceuticals, Arrowhead Pharmaceuticals Inc., and Adverum.

More Trending Topics from Fortune Business Insights:

Breast Cancer Therapeutics Market 2019-2026: Global Trends, Industry Analysis, Growth Factor, Research Reports

Advanced Wound Care Market Size, Share, Top Segmentation, Regional Growth & Global Trends by 2025 | Fortune Business Insights

Bone Growth Stimulators Market 2019 Highlights by Surgery Type and End User | Phenomenal Growth of 4.6% with Top Players by 2026

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Tags

Jesus Rust

Jesus is leading the environment column. He is a very renowned environmentalist and has worked in many projects, some of which are based in faraway lands too. He always encourages environment conservation and sometimes keeps small group talks about the concerns. His writing and editing skills act the cheery on the top of the cake.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close